Identification of long-non coding RNA UCA1 as an oncogene in renal cell carcinoma.

Renal cell carcinoma (RCC) is the most common type of kidney cancer in adults, which is associated with poor prognosis and high recurrence. Long non‑coding RNAs (lncRNAs) have been reported to be dysregulated in cancer and to be important in the regulation of carcinogenesis, thus suggesting that this class of molecules may be used as biomarkers in cancer. The lncRNA urothelial carcinoma associated 1 (UCA1) has been observed to be upregulated and to function as an oncogene in certain types of cancer; however, the role of UCA1 in RCC remains to be elucidated. The present study aimed to determine the expression and function of UCA1 in RCC. Quantitative polymerase chain reaction (qPCR) was used to determine the expression levels of UCA1 in 46 paired RCC and adjacent normal tissue samples. Furthermore, qPCR was used to determine the expression levels of UCA1 in four RCC cell lines compared with the human embryonic kidney 293T cell line. The impact of UCA1 on cell migration, proliferation and apoptosis was investigated by wound scratch assay, MTT and flow cytometry, respectively. The results of the present study demonstrated that UCA1 expression levels were significantly increased in RCC tissues and cells, as compared with the controls. Ectopic expression and gene silencing of UCA1 in RCC cell lines exerted opposite effects on cellular proliferation, migration and apoptosis, and the results suggested that UCA1 may function as an oncogene in RCC. These results indicated that UCA1 may be considered as a promising biomarker for diagnosis, and a therapeutic target in RCC. Further research is required to elucidate the role and target genes of UCA1 in RCC.

[1]  Wei Chen,et al.  Urothelial carcinoma associated 1 is a hypoxia-inducible factor-1α-targeted long noncoding RNA that enhances hypoxic bladder cancer cell proliferation, migration, and invasion , 2014, Tumor Biology.

[2]  Mei Xue,et al.  Long non-coding RNA UCA1 promotes glycolysis by upregulating hexokinase 2 through the mTOR–STAT3/microRNA143 pathway , 2014, Cancer science.

[3]  C. Ponting,et al.  Evolution and Functions of Long Noncoding RNAs , 2009, Cell.

[4]  T. Kwok,et al.  Induction of drug resistance and transformation in human cancer cells by the noncoding RNA CUDR. , 2007, RNA.

[5]  Carolyn J. Brown,et al.  The functional role of long non-coding RNA in human carcinomas , 2011, Molecular Cancer.

[6]  Y. Mo,et al.  Long non-coding RNA UCA1 promotes breast tumor growth by suppression of p27 (Kip1) , 2014, Cell Death and Disease.

[7]  D. Dalela,et al.  Appraisal of diagnostic ability of UCA1 as a biomarker of carcinoma of the urinary bladder , 2014, Tumor Biology.

[8]  Han Hao,et al.  [Evaluation of novel gene UCA1 as a tumor biomarker for the detection of bladder cancer]. , 2012, Zhonghua yi xue za zhi.

[9]  R. Spizzo,et al.  Long non-coding RNAs and cancer: a new frontier of translational research? , 2012, Oncogene.

[10]  J. Mattick,et al.  Long non-coding RNAs: insights into functions , 2009, Nature Reviews Genetics.

[11]  F. McGovern,et al.  Renal-cell carcinoma. , 2005, The New England journal of medicine.

[12]  D. Madoff,et al.  Epidemiology and Staging of Renal Cell Carcinoma , 2014, Seminars in Interventional Radiology.

[13]  Xu Li,et al.  UCA1, a non‐protein‐coding RNA up‐regulated in bladder carcinoma and embryo, influencing cell growth and promoting invasion , 2008, FEBS letters.

[14]  Chen Yang,et al.  Long non-coding RNA UCA1a(CUDR) promotes proliferation and tumorigenesis of bladder cancer. , 2012, International journal of oncology.

[15]  M. Yandell,et al.  Coordinated control of senescence by lncRNA and a novel T-box3 co-repressor complex , 2014, eLife.

[16]  Thomas D. Schmittgen,et al.  Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method. , 2001, Methods.

[17]  Yu Fan,et al.  Long non‐coding RNA UCA1 increases chemoresistance of bladder cancer cells by regulating Wnt signaling , 2014, The FEBS journal.

[18]  Xiaobing Fu,et al.  Long Noncoding RNAs: Insights from Biological Features and Functions to Diseases , 2013, Medicinal research reviews.

[19]  Meng Li,et al.  Rapid Identification of UCA1 as a Very Sensitive and Specific Unique Marker for Human Bladder Carcinoma , 2006, Clinical Cancer Research.

[20]  R. Motzer,et al.  Renal-cell carcinoma. , 1996, The New England journal of medicine.

[21]  Chen Yang,et al.  Long non-coding RNA UCA1 regulated cell cycle distribution via CREB through PI3-K dependent pathway in bladder carcinoma cells. , 2012, Gene.

[22]  M. Takagi,et al.  Regulation of p53 Translation and Induction after DNA Damage by Ribosomal Protein L26 and Nucleolin , 2005, Cell.

[23]  Yaoting Gui,et al.  Hsa-miR-1 downregulates long non-coding RNA urothelial cancer associated 1 in bladder cancer , 2014, Tumor Biology.

[24]  Xuefei Shi,et al.  Long non-coding RNAs: a new frontier in the study of human diseases. , 2013, Cancer letters.

[25]  Z. Fang,et al.  Potential roles of abnormally expressed long noncoding RNA UCA1 and Malat-1 in metastasis of melanoma , 2014, Melanoma research.

[26]  John T. Wei,et al.  Transcriptome sequencing across a prostate cancer cohort identifies PCAT-1, an unannotated lincRNA implicated in disease progression , 2011, Nature Biotechnology.

[27]  Lin Yang,et al.  Long noncoding RNAs: fresh perspectives into the RNA world. , 2014, Trends in biochemical sciences.

[28]  Peng Huang,et al.  UCA1, a long non-coding RNA up-regulated in colorectal cancer influences cell proliferation, apoptosis and cell cycle distribution , 2014, Pathology.

[29]  T. Mak,et al.  Regulation of cancer cell metabolism , 2011, Nature Reviews Cancer.

[30]  Wenjing Wu,et al.  Ets-2 Regulates Cell Apoptosis via the Akt Pathway, through the Regulation of Urothelial Cancer Associated 1, a Long Non-Coding RNA, in Bladder Cancer Cells , 2013, PloS one.

[31]  George A Calin,et al.  Long noncoding RNA in prostate, bladder, and kidney cancer. , 2014, European urology.

[32]  Shou-zhen Wu,et al.  Upregulation of long non-coding RNA urothelial carcinoma associated 1 by CCAAT/enhancer binding protein α contributes to bladder cancer cell growth and reduced apoptosis , 2014, Oncology reports.

[33]  J. Meigs,et al.  Epidemiology of renal cell carcinoma in Connecticut, 1935-1973. , 1976, Journal of the National Cancer Institute.